2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Oppositional Defiant Disorder: new trials by email Literature Review of Oppositional Defiant Disorder trials Research Report on Oppositional Defiant Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pathways 2 Success L2B, L2B + App, skills for success - Conduct Disorder, Oppositional Defiant Disorder | Phase 1 / Phase 2 | Recruiting | University of Minnesota | 120 | 2025-03-12 | 2026-04-13 |
| Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders Ziprasidone Hydrochloride, Placebo - Conduct Disorder, Oppositional Defiant Disorder | Phase 2 | Completed | University Hospital Freiburg | 51 | 2006-07-01 | 2008-11-18 |
| Home Based Treatment for Drug Use in Early Adolescents Adolescent Skills Parent Management Parent-Adol Negotiation, Treatment as Usual - Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder | Phase 2 | Completed | University of Pittsburgh | 36 | 2006-01-01 | 2011-05-26 |
Conduct Disorder (3) · Alcohol Drinking (1) · Attention Deficit Disorder with Hyperactivity (1) · Substance-Related Disorders (1)
Attention Deficit and Disruptive Behavior Disorders (3) · Mental Disorders (3) · Neurodevelopmental Disorders (3) · Behavior (1) · Chemically-Induced Disorders (1) · Drinking Behavior (1)
Amyloid (1) · Therapeutics (1) · ziprasidone (1)
University Hospital Freiburg (1) · University of Minnesota (1) · University of Pittsburgh (1)
United States (2) · Germany (1)
Christian Fleischhaker, MD (1) · Eberhard Schulz, MD (1) · Klaus Hennighausen, MD (1) · Oscar G Bukstein, M.D., M.P.H. (1) · Timothy Piehler (1)
R21DA016631 (1)